Cargando…

Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung Cancer

Nivolumab is a humanized IgG4 and programmed death 1 (PD-1) monoclonal antibody that has demonstrated antitumor efficacy in clinical trials of various malignant tumors including non-small-cell lung cancer and head and neck squamous cell carcinoma (SCC). However, patients with multiple primary malign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Teppei, Sakurai, Kazuo, Kuroda, Makoto, Imaizumi, Kazuyoshi, Hida, Toyoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649270/ https://www.ncbi.nlm.nih.gov/pubmed/29070993 http://dx.doi.org/10.1159/000479960

Ejemplares similares

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
por: Yamaguchi, Teppei, et al.
Publicado: (2019)

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety
por: Hida, Toyoaki
Publicado: (2018)

Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
por: Oya, Yuko, et al.
Publicado: (2017)

Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer
por: Tsushima, Nayuta, et al.
Publicado: (2020)

Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis
por: Yamaguchi, Teppei, et al.
Publicado: (2021)

Clinical outcomes for 61 cases of hypopharyngeal cancer with synchronous esophageal cancer
por: Yang, Shixuan, et al.
Publicado: (2019)

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer
por: Hida, Toyoaki, et al.
Publicado: (2017)

Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information
por: Yamaguchi, Teppei, et al.
Publicado: (2021)

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
por: Yamasaki, Masahiro, et al.
Publicado: (2017)

Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors
por: Nishio, Makoto, et al.
Publicado: (2022)

Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
por: Nishio, Makoto, et al.
Publicado: (2017)

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020)

Efficacy of endoscopy under general anesthesia for the detection of synchronous lesions in oral hypopharyngeal cancer
por: Ono, Yoichiro, et al.
Publicado: (2023)

Pharmacokinetics of Gefitinib in a Patient with Non-Small Cell Lung Cancer Undergoing Continuous Ambulatory Peritoneal Dialysis
por: Yamaguchi, Teppei, et al.
Publicado: (2015)

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

CD271 regulates the proliferation and motility of hypopharyngeal cancer cells
por: Mochizuki, Mai, et al.
Publicado: (2016)

Successful Treatment of Synchronous Double Lung Primary Malignancies and Colon Cancer
por: Alghanmi, Hosam A
Publicado: (2022)

CD271 Defines a Stem Cell-Like Population in Hypopharyngeal Cancer
por: Imai, Takayuki, et al.
Publicado: (2013)

Synchronous Double Primary Cancer Complicated With Severe Hypercalcemia
por: Alçada, Martim, et al.
Publicado: (2023)

Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients
por: Seto, Katsutoshi, et al.
Publicado: (2020)

Nivolumab in Metastatic Non–Small Cell Lung Cancer
por: Deel, Andrea
Publicado: (2016)

Bile reflux and hypopharyngeal cancer
por: Vageli, Dimitra P., et al.
Publicado: (2021)

Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
por: Kuroda, Hiroaki, et al.
Publicado: (2018)

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)

Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
por: Taniai, Tomohiko, et al.
Publicado: (2018)

Bicytopenia in Primary Lung Melanoma Treated with Nivolumab
por: Takahashi, Ayumu, et al.
Publicado: (2018)

Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer
por: Sata, Masafumi, et al.
Publicado: (2021)

Synchronous Double Bile Duct Cancers with Distinct Genetic Features
por: Morita, Shinichi, et al.
Publicado: (2020)

RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer
por: Nakazato, Akira, et al.
Publicado: (2022)

First‐line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non‐squamous non‐small cell lung cancer: Updated survival analysis of the ONO‐4538‐52/TASUKI‐52 randomized controlled trial
por: Kim, Hye Ryun, et al.
Publicado: (2023)

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis
por: Hirashima, Tomonori, et al.
Publicado: (2019)

Imaging of hypopharyngeal and cervical oesophageal cancer
por: Hermans, R
Publicado: (2003)

Concurrent radiochemotherapy in advanced hypopharyngeal cancer
por: Krstevska, Valentina, et al.
Publicado: (2010)

Large neck metastasis of hypopharyngeal cancer
por: Ralli, Massimo, et al.
Publicado: (2019)

A Case of Synchronous Double Primary Lung Cancer Presenting with Pleomorphic Carcinoma and Adenocarcinoma
por: Taira, Naohiro, et al.
Publicado: (2014)

Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies
por: Horinouchi, Hidehito, et al.
Publicado: (2019)

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies
por: Saka, Hideo, et al.
Publicado: (2020)

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies
por: Uozu, Sakurako, et al.
Publicado: (2017)

Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
por: Zhang, Zhirong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ti2kn4vlb4qlvvvc5jb5pttb2